USPTO trademark

RIVFLOZA

RegisteredUSPTOWord markClass 5Class 42

"RIVFLOZA" is a word mark owned by Novo Nordisk Health Care AG, filed at the USPTO on September 18, 2020. It is registered and covers classes 5 and 42.

View Novo Nordisk Health Care AG portfolioGet this data via the API
Official USPTO record
RIVFLOZA trademark as filed
As filed with the USPTO
Status
Registered
Since August 20, 2024
Filed
September 18, 2020
Registered
August 20, 2024
Expires
Not recorded
Application no.
90191150
Registration no.
7482490
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns RIVFLOZA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Novo Nordisk Health Care AG

Zürich, Switzerland

584 trademarks in the portfolioView company

Representative

Spencer Beall

White & Case LLP

Goods and services

What the mark covers

The products and services RIVFLOZA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the treatment of various diseases, namely, pharmaceutical preparations for the treatment of rare diseases in the nature of genetic disorders, chronic liver diseases, cardiovascular diseases, cancers, and viral infections; drug delivery agents in the nature of oligonucleotide compounds for use in the targeted delivery of RNAi therapy; chemical compounds that act as a platform for the delivery of drugs in the nature of drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals

  • Scientific research and development of pharmaceutical preparations, compounds for use in the targeted delivery of therapy, chemical compounds that act as a platform for the delivery of drugs, and drug delivery agents; scientific research and development; scientific investigations for medical purposes; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Notice of acceptance of statement of use e-mailed
  4. Allowed principal register - sou accepted
  5. Statement of use processing complete
  6. Case assigned to intent to use paralegal
  7. Use amendment filed
  8. Teas statement of use received
  9. Notice of approval of extension request e-mailed
  10. Sou extension 4 granted

10 earlier steps on the official record.

FAQ

About RIVFLOZA

Who owns the trademark "RIVFLOZA"?

The USPTO trademark "RIVFLOZA" (application 90191150) is owned by Novo Nordisk Health Care AG.

What is the status of "RIVFLOZA"?

Its status at the USPTO is: registered.

When was "RIVFLOZA" registered?

It was registered on August 20, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RIVFLOZA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2c44-a4a3-7719-8af8-1660f6c87618
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2c44-a4a3-7719-8af8-1660f6c87618",
  "object": "trademark",
  "mark_text": "RIVFLOZA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90191150",
  "filing_date": "2020-09-18",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "NOVO NORDISK HEALTH CARE AG",
      "entity_id": "ent_019eb6fb-c8d8-774d-8f4b-f2b88f5c8227"
    }
  ]
}